当前位置:首页 - 行情中心 - 恒而达(300946) - 财务分析 - 利润表

恒而达

(300946)

  

流通市值:39.04亿  总市值:80.34亿
流通股本:7580.43万   总股本:1.56亿

利润表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、营业总收入319,512,173.51150,303,517.14585,232,376.05441,094,240.64
  营业收入319,512,173.51150,303,517.14585,232,376.05441,094,240.64
二、营业总成本263,958,641.41121,962,547.78483,306,993.38351,849,939.13
  营业成本225,204,325.58106,472,801.59413,134,746.76302,792,361.29
  税金及附加2,673,405.321,075,661.285,034,925.983,931,473.4
  销售费用8,399,698.133,350,955.0116,575,392.6710,911,219.79
  管理费用16,178,497.986,537,346.6826,325,143.4817,911,265.11
  研发费用9,242,025.753,877,372.1120,367,933.6714,902,518.4
  财务费用2,260,688.65648,411.111,868,850.821,401,101.14
  其中:利息费用1,741,366.43743,279.952,759,505.621,558,309.46
  其中:利息收入250,530.39182,818.95569,977.96380,404.12
三、其他经营收益
  加:公允价值变动收益178,529.35178,529.35298,322.23298,322.23
  加:投资收益460,495.28-28,759.7711,753.9787,027.22
  资产减值损失(新)-8,641,704.3-4,342,411.39-9,234,103.92-3,230,820.76
  信用减值损失(新)-2,444,194.59-1,223,318.57-1,848,092.45-1,869,721.71
  其他收益4,510,135.35408,208.168,446,443.416,534,822.81
四、营业利润49,616,793.1923,333,217.1499,599,705.9191,063,931.3
  加:营业外收入352,434.091,515.5110,356.16311.06
  减:营业外支出300,505.67263,931.7703,059.04701,051.94
五、利润总额49,668,721.6123,070,800.9598,907,003.0390,363,190.42
  减:所得税费用6,557,697.222,897,905.0311,685,387.5511,246,853.05
六、净利润43,111,024.3920,172,895.9287,221,615.4879,116,337.37
(一)按经营持续性分类
  持续经营净利润43,111,024.3920,172,895.9287,221,615.4879,116,337.37
(二)按所有权归属分类
  归属于母公司股东的净利润43,109,369.3920,019,806.3287,312,337.2679,006,329.29
  少数股东损益1,655153,089.6-90,721.78110,008.08
  扣除非经常损益后的净利润41,672,762.0619,921,107.5983,887,508.6777,112,068.69
七、每股收益
  (一)基本每股收益0.280.170.730.66
  (二)稀释每股收益0.280.170.730.66
八、其他综合收益2,897,336.7---
  归属于母公司股东的其他综合收益2,897,336.7---
九、综合收益总额46,008,361.0920,172,895.9287,221,615.4879,116,337.37
  归属于母公司股东的综合收益总额46,006,706.0920,019,806.3287,312,337.2679,006,329.29
  归属于少数股东的综合收益总额1,655153,089.6-90,721.78110,008.08
公告日期2025-08-292025-04-292025-04-192024-10-29
审计意见(境内)标准无保留意见
TOP↑